Health Care/Hospital

China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results

-- 3Q09 Revenue Increases 43% Over Prior Year Third Quarter; Net Income Up Over 200%, Exceeding Company's Internal Projections -- GANSU, China, May 18 /PRNewswire-Asia/ -- China Dasheng Biotechnology Company ("China Dasheng" or "the Company") (OTC Bulletin Board: CDBT), a leading produce...

2009-05-18 20:30 356

China Biologic Products Announces 2009 First Quarter Results Conference Call

TAI’AN CITY, Shandong, China, May 18 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People’s Republic of China ("PRC"), today announced that it will host a conferen...

2009-05-18 18:00 550

China Shenghuo Reports Unaudited Financial Results for the First Quarter of 2009

KUNMING, China, May 16 /PRNewswire-Asia/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Amex Equities: KUN) ("China Shenghuo" or the "Company"), which is engaged in the research, development, manufacture, and marketing of pharmaceutical, nutritional supplement and cosmetic products in the...

2009-05-16 04:00 497

Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2009 Financial Results

CHENGDU, China, May 15 /PRNewswire-Asia/ -- - Third Quarter 2009 Revenue Increased 7.4% to $9.9 Million while Net Income Increased 48.8% to $1.9 Million with EPS of $0.10 - Revenue for the First Nine Months Increased 22.4 % to $29.6 Million, Net Income Increased 29.2% ...

2009-05-15 21:00 489

China Medicine Wins Best 1000 SME Award in Guangdong Province; Eligible for RMB 25 Million Loan

GUANGZHOU, China, May 15 /PRNewswire-Asia/ -- China Medicine Corporation (OTC Bulletin Board: CHME) (“China Medicine” or “the Company”), a leading distributor and developer of prescription and over-the-counter pharmaceuticals, traditional Chinese medicines (“TCM”), nutritional and dietary-su...

2009-05-15 21:00 479

China Biologic Products to Present at CCG IR’s China Rising Conference and Oppenheimer’s China Dragon Call Conference in New York

TAIAN CITY, Shandong, China, May 15 /PRNewswire-Asia/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) (“China Biologic” or the “Company”), one of the leading plasma-based pharmaceutical companies in the People’s Republic of China (“PRC”), today announced that the Company’s management...

2009-05-15 20:00 578

Tiens Biotech Group (USA) Reports First Quarter Results

NEW YORK, May 15 /PRNewswire-Asia/ -- Tiens Biotech Group (USA), Inc. (the "Company" or "Tiens", NYSE Amex: TBV), http://www.tiens-bio.com , today announced financial results for the first quarter ended March 31, 2009. Revenue for the first quarter of 2009 increased 42% to $18.2 million, ...

2009-05-15 19:00 435

Shengtai Pharmaceutical, Inc. Reports Unaudited Third Quarter Fiscal 2009 Financial Results

-- Glucose Product Shipments Increased 18% Year-Over-Year to 22,407 Metric Tons -- Customer Deposits Rise for New Production WEIFANG, Shandong, China, May 15 /PRNewswire-Asia-FirstCall/ -- Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) ("Shengtai" or "the Company"), a leading...

2009-05-15 18:30 440

China Pharma Holdings, Inc. Reports First Quarter 2009 Financial Results

-- Revenue Increased 10.9% Y-O-Y to $13.0 million -- -- Great Potential for New Products and Continued Strong Demand for Existing Products -- -- Increased Marketing Efforts and Distribution Expansion to Drive Future Revenue -- HAIKOU CITY, China, May 15 /PRNewswire-Asia-FirstCall/...

2009-05-15 18:00 647

Roche to Present Major Advances With Targeted Cancer Medicines at ASCO

BASEL, Switzerland, May 15 /PRNewswire-Asia/ -- More than 500 scientific abstracts to be presented across 20 types of cancers. Results could significantly improve the way cancer is treated for patients with inoperable stomach cancer; advanced melanoma; lung and breast cancers. ...

2009-05-15 06:00 478

Gold Rock Changed Name to RainEarth Inc. and Launches New English Web Site

BEIJING, May 15 /PRNewswire-Asia/ -- Gold Rock Resources Inc. (OTC Bulletin Board: GRKR), a company that recently entered into the consultant services related to the hollow fiber membrane materials' application and manufacturing market in China announced that has changed its name to: RainEarth...

2009-05-15 05:22 556

WuXi PharmaTech Announces First-Quarter 2009 Results

SHANGHAI, May 15 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial results...

2009-05-15 04:30 553

Corning Sees Positive Growth Opportunities in Life Sciences in China

Corning’s cutting-edge technology and innovation benefiting pharmaceutical industry BEIJING, May 15 /PRNewswire-Asia/ -- Notwithstanding the current economic downturn that has left few industries unscathed, the life sciences industry in China holds great promise because of the increasing dema...

2009-05-15 16:00 651

BMP Sunstone To Report First Quarter 2009 Financial Results

PLYMOUTH MEETING, Pa., May 14 /PRNewswire-Asia/ -- BMP Sunstone Corporation (Nasdaq: BJGP) ("BMP Sunstone" or the "Company") today announced that the Company plans to release first quarter 2009 financial results on Monday, May 18, 2009, after the market closes. The Company will hold a con...

2009-05-14 21:37 592

China Sky One Medical, Inc. Announces Record First Quarter 2009 Results

HARBIN, China, May 14 /PRNewswire-Asia/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company in the People's Republic of China ("PRC"), today announced record financial results for the first quarter of 2009. ...

2009-05-14 20:38 647

Nucletron Releases Comprehensive Film-and Volume-Based Planning System for Wide Variety of Brachy Solutions

VEENENDAAL, The Netherlands, May 14 /PRNewswire-Asia/ -- Nucletron, a knowledge-based leader in radiation oncology, today announced a new release of Oncentra(R) Brachy, a comprehensive film- and volume-based treatment planning system to optimize cancer treatment planning for brachytherapy. Oncen...

2009-05-15 03:10 553

Domain Registration Corp Successfully Completes Reverse Merger

BioPharm Asia, Inc. Proposed as New Corporate Name to Reflect Focus in China's Growing Pharmaceutical Market SHENZHEN, China, May 14 /PRNewswire-Asia/ -- Domain Registration Corp. (OTC Bulletin Board: DOMR), today announced that on May 7, 2009, the Company acquired all of the outstandin...

2009-05-14 15:59 521

HUYA Bioscience Announces Strategic Alliance With Abbott on Drug and Biomarker Development Candidates From China

Collaboration will leverage HUYA's growing Chinese bioscience network SAN DIEGO, May 14 /PRNewswire-Asia/ -- HUYA Bioscience International, a leader in US/China pharmaceutical co-development, today announced an agreement with Abbott to identify and pursue proprietary preclinical and clinica...

2009-05-14 11:34 585

U.S. FDA Accepts Aridol(TM) New Drug Application for Review

SYDNEY, May 14 /PRNewswire-Asia/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced it had received notification from the United States Food and Drug Administration (FDA) that the New Drug Application (NDA) for its mannitol bronchial challenge test Aridol(TM) has been accepted for standard ...

2009-05-14 08:11 435

Jiangbo Pharmaceuticals, Inc. Announces Conference Call to Discuss Results for its Third Quarter of FY 2009

LAIYANG, China, May 14 /PRNewswire-Asia/ -- Jiangbo Pharmaceuticals, Inc., (OTC Bulletin Board: JGBO; "Jiangbo" or the "Company") (which recently changed its name from Genesis Pharmaceuticals Enterprises, Inc., OTC Bulletin Board: GNPH), a U.S. pharmaceutical company with its principal operation...

2010-07-09 21:20 667
1 ... 704705706707708709710 ... 785

Week's Top Stories